{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:47:43Z","timestamp":1790668063095,"version":"4.1.0"},"reference-count":121,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T00:00:00Z","timestamp":1593216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,27]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused significant morbidity and mortality for patients and stressed healthcare systems worldwide. The clinical features and outcomes of COVID-19 among immunosuppressed patients, who are at presumed risk of more severe disease but who may also have decreased detrimental inflammatory responses, are not well characterized. We review the existing literature on COVID-19 among immunocompromised populations ranging from patients with cancer and solid-organ transplant recipients to patients with HIV and those receiving immunomodulatory therapy for autoimmune disease. Patients with malignancy and solid-organ transplant recipients may be at increased risk of severe COVID-19 disease and death, whereas for those with other types of immunocompromise, current evidence is less clear. Overall, further prospective controlled studies are needed to determine the attributable risk of immunocompromising conditions and therapies on COVID-19 disease prognosis.<\/jats:p>","DOI":"10.1093\/cid\/ciaa863","type":"journal-article","created":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T03:21:54Z","timestamp":1592968914000},"page":"340-350","source":"Crossref","is-referenced-by-count":422,"title":["COVID-19 in Immunocompromised Hosts: What We Know So Far"],"prefix":"10.1093","volume":"72","author":[{"given":"Monica","family":"Fung","sequence":"first","affiliation":[{"name":"Division of Infectious Disease, Department of Medicine, University of California, San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M","family":"Babik","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease, Department of Medicine, University of California, San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,6,27]]},"reference":[{"key":"2021012703151780200_CIT0001","author":"World Health Organization","year":"2019"},{"key":"2021012703151780200_CIT0002","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","article-title":"An interactive web-based dashboard to track COVID-19 in real time","volume":"20","author":"Dong","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"2021012703151780200_CIT0003","doi-asserted-by":"crossref","first-page":"e13511","DOI":"10.1111\/ctr.13511","article-title":"RNA respiratory viral infections in solid organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Manuel","year":"2019","journal-title":"Clin Transplant"},{"key":"2021012703151780200_CIT0004","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1182\/blood-2016-01-634873","article-title":"How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantation","volume":"127","author":"Waghmare","year":"2016","journal-title":"Blood"},{"key":"2021012703151780200_CIT0005","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"2021012703151780200_CIT0006","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.abb8925","article-title":"Cytokine release syndrome in severe COVID-19","volume":"368","author":"Moore","year":"2020","journal-title":"Science"},{"key":"2021012703151780200_CIT0007","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41577-020-0312-7","article-title":"COVID-19: risk for cytokine targeting in chronic inflammatory diseases?","volume":"20","author":"Schett","year":"2020","journal-title":"Nat Rev Immun"},{"key":"2021012703151780200_CIT0008","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"2021012703151780200_CIT0009","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"2021012703151780200_CIT0010","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1158\/2159-8290.CD-20-0422","article-title":"Patients with cancer appear more vulnerable to SARS-CoV-2: a multi-center study during the COVID-19 outbreak","volume":"10","author":"Dai","year":"2020","journal-title":"Cancer Discov"},{"key":"2021012703151780200_CIT0011","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1158\/2159-8290.CD-20-0516","article-title":"Case fatality rate of cancer patients with COVID-19 in a New York Hospital system","volume":"10","author":"Mehta","year":"2020","journal-title":"Cancer Discov"},{"key":"2021012703151780200_CIT0012","first-page":"0","article-title":"Clinical characteristics and outcomes of cancer patients with COVID-19","author":"Yang","year":"2020","journal-title":"J Med Virol"},{"key":"2021012703151780200_CIT0013","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S1470-2045(20)30309-0","article-title":"Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study","volume":"21","author":"Tian","year":"2020","journal-title":"Lancet Oncol"},{"key":"2021012703151780200_CIT0014","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","article-title":"Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China","volume":"21","author":"Liang","year":"2020","journal-title":"Lancet Oncol"},{"key":"2021012703151780200_CIT0015","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/jamaoncol.2020.0980","article-title":"SARS-CoV-2 Transmission in patients with cancer at a tertiary care hospital in Wuhan, China","volume":"6","author":"Yu","year":"2020","journal-title":"JAMA Oncol"},{"key":"2021012703151780200_CIT0016","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.annonc.2020.03.296","article-title":"Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China","volume":"31","author":"Zhang","year":"2020","journal-title":"Ann Oncol"},{"key":"2021012703151780200_CIT0017","first-page":"S0923","article-title":"Do patients with cancer have a poorer prognosis of COVID-19? an experience in New York City","author":"Miyashita","year":"2020","journal-title":"Ann Oncol"},{"key":"2021012703151780200_CIT0018","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S1470-2045(20)30310-7","article-title":"Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study","volume":"21","author":"Yang","year":"2020","journal-title":"Lancet Oncol"},{"key":"2021012703151780200_CIT0019","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(20)31187-9","article-title":"Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study","volume":"395","author":"Kuderer","year":"2020","journal-title":"Lancet"},{"key":"2021012703151780200_CIT0020","first-page":"1919","article-title":"COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study","volume":"395","author":"Lee","year":"2020","journal-title":"La"},{"key":"2021012703151780200_CIT0021","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1038\/s41375-020-0836-7","article-title":"COVID-19 in persons with haematological cancers","volume":"34","author":"He","year":"2020","journal-title":"Leukemia"},{"key":"2021012703151780200_CIT0022","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1182\/blood.2020006288","article-title":"The BTK-inhibitor ibrutinib may protect against pulmonary injury in COVID-19 infected patients","volume":"135","author":"Treon","year":"2020","journal-title":"Blood"},{"key":"2021012703151780200_CIT0023","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1111\/bjh.16801","article-title":"Survival study of hospitalized patients with concurrent Covid-19 and haematological malignancies","volume":"190","author":"Mart\u00edn-Moro","year":"2020","journal-title":"Br J Haematol"},{"key":"2021012703151780200_CIT0024","doi-asserted-by":"crossref","DOI":"10.1038\/s41409-020-0931-4","article-title":"COVID-19 outcomes in patients with hematologic disease","author":"Malard","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"2021012703151780200_CIT0025","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.16906","article-title":"A case series of MGUS and COVID-19","author":"Gonzalez-Lugo","year":"2020","journal-title":"Br J Haematol"},{"key":"2021012703151780200_CIT0026","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.16852","article-title":"Clinical outcome of coronavirus disease 2019 in haemato-oncology patients","author":"Aries","year":"2020","journal-title":"Br J Haematol"},{"key":"2021012703151780200_CIT0027","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.16856","article-title":"Covid-19 in bone marrow transplant recipients: reflecting on a single centre experience","author":"Kanellopoulos","year":"2020","journal-title":"Br J Haematol"},{"key":"2021012703151780200_CIT0028","first-page":"19","article-title":"Following-up allogeneic transplantation recipients during the COVID-19 pandemic","volume":"3026","author":"Lupo-Stanghellini","year":"2020","journal-title":"Lancet Haematol"},{"key":"2021012703151780200_CIT0029","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1038\/s41375-020-0853-6","article-title":"COVID-19 in persons with chroni","volume":"34","author":"Li","year":"2020","journal-title":"Leukemia"},{"key":"2021012703151780200_CIT0030","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1038\/s41375-020-0879-9","article-title":"Multiple myeloma and COVID-19","volume":"34","author":"Dhakal","year":"2020","journal-title":"Leukemia"},{"key":"2021012703151780200_CIT0031","first-page":"bjh.16863","article-title":"Protective role of Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukaemia and COVID-19","volume":"2019","author":"Thibaud","year":"2020","journal-title":"Br J Haematol"},{"key":"2021012703151780200_CIT0032","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1016\/j.jtho.2020.02.025","article-title":"Treatment and outcome of a patient with lung cancer infected with severe acute respiratory syndrome coronavirus-2","volume":"15","author":"Zhang","year":"2020","journal-title":"J Thorac Oncol"},{"key":"2021012703151780200_CIT0033","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1016\/j.jtho.2020.04.005","article-title":"Alert to potential contagiousness: a case of lung cancer with asymptomatic SARS-CoV-2 infection","volume":"15","author":"Ouyang","year":"2020","journal-title":"J Thorac Oncol"},{"key":"2021012703151780200_CIT0034","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1111\/ajt.15896","article-title":"COVID-19 in post-transplantation patients\u2014report of two cases","volume":"20","author":"Huang","year":"2020","journal-title":"Am J Transplant"},{"key":"2021012703151780200_CIT0035","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1111\/bjh.16787","article-title":"IL-6 blockade treatment for severe COVID-19 in two patients with multiple myeloma","volume":"190","author":"Chaidos","year":"2020","journal-title":"Br J Haematol"},{"key":"2021012703151780200_CIT0036","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1182\/bloodadvances.2020001907","article-title":"First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab","volume":"4","author":"Zhang","year":"2020","journal-title":"Blood Adv"},{"key":"2021012703151780200_CIT0037","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/bjh.16798","article-title":"Outcome of a patient with refractory Hodgkin\u2019s Lymphoma on pembrolizumab, infected with SARS-CoV-2","volume":"190","author":"Kelly","year":"2020","journal-title":"Br J Haematol"},{"key":"2021012703151780200_CIT0038","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1111\/ajt.15929","article-title":"COVID-19 in solid organ transplant recipients: a single-center case series from Spain","volume":"20","author":"Fern\u00e1ndez-Ruiz","year":"2020","journal-title":"Am J Transplant"},{"key":"2021012703151780200_CIT0039","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.eururo.2020.03.039","article-title":"Coronavirus disease 2019 pneumonia in immunosuppressed renal transplant recipients: a summary of 10 confirmed cases in Wuhan, China","volume":"77","author":"Zhu","year":"2020","journal-title":"Eur Urol"},{"key":"2021012703151780200_CIT0040","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1681\/ASN.2020030375","article-title":"Early description of coronavirus 2019 disease in kidney transplant recipients in New York","volume":"31","author":"Columbia University Kidney Transplant Program","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"2021012703151780200_CIT0041","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1056\/NEJMc2011117","article-title":"Covid-19 and kidney transplantation","volume":"382","author":"Akalin","year":"2020","journal-title":"N Engl J Med"},{"key":"2021012703151780200_CIT0042","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1111\/ajt.15941","article-title":"COVID-19 in solid organ transplant recipients: initial report from the US epicenter","volume":"20","author":"Pereira","year":"2020","journal-title":"Am J Transplant"},{"key":"2021012703151780200_CIT0043","first-page":"941","article-title":"Preliminary analysis of the impact of COVID-19 outbreak on Italian liver transplant prog","volume":"26","author":"Agnes","year":"2020","journal-title":"Liver Transpl"},{"key":"2021012703151780200_CIT0044","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cardfail.2020.05.008","article-title":"Coronavirus disease-2019 in heart transplant recipients in southeastern Michigan: a case series","volume":"26","author":"Ketcham","year":"2020","journal-title":"J Card Fail"},{"key":"2021012703151780200_CIT0045","first-page":"1","article-title":"Characteristics and outcomes of recipients of heart transplant with coronavirus disease 2019","volume":"10032","author":"Latif","year":"2020","journal-title":"JAMA Cardiol"},{"key":"2021012703151780200_CIT0046","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13353","article-title":"Outcome of COVID-19 in liver transplant recipients: a preliminary report from Northwestern Italy","author":"Patrono","year":"2020","journal-title":"Transpl Infect Dis"},{"key":"2021012703151780200_CIT0047","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0000000000003339","article-title":"Early experience with COVID-19 and solid organ transplantation at a US high-volume transplant center","author":"Yi","year":"2020","journal-title":"Transplantation"},{"key":"2021012703151780200_CIT0048","article-title":"COVID-19 in elderly kidney transplant recipients","author":"Crespo","year":"2020","journal-title":"Am J Transplant"},{"key":"2021012703151780200_CIT0049","doi-asserted-by":"crossref","DOI":"10.1111\/tri.13662","article-title":"Covid-19 in solid organ transplant recipients: a single center experience","author":"Hoek","year":"2020","journal-title":"Transpl Int"},{"key":"2021012703151780200_CIT0050","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.16069","article-title":"Clinical outcome in solid organ transplant recipients with COVID-19: a single-center experience","author":"Travi","year":"2020","journal-title":"Am J Transplant"},{"key":"2021012703151780200_CIT0051","doi-asserted-by":"crossref","DOI":"10.2215\/CJN.05170420","article-title":"Early outcomes of outpatient management of kidney transplant recipients with coronavirus disease 2019","author":"Husain","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021012703151780200_CIT0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.eururo.2020.04.064","article-title":"Clinical course, imaging features, and outcomes of COVID-19 in kidney transplant recipients","author":"Abrishami","year":"2020","journal-title":"Eur Urol"},{"key":"2021012703151780200_CIT0053","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1111\/ajt.15967","article-title":"COVID-19 in kidney transplant recipients","volume":"20","author":"Nair","year":"2020","journal-title":"Am J Transplant"},{"key":"2021012703151780200_CIT0054","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.15970","article-title":"Preliminary data on outcomes of SARS-CoV-2 infection in a Spanish single centre cohort of kidney recipients","author":"Montagud-Marrahi","year":"2020","journal-title":"Am J Transplant"},{"key":"2021012703151780200_CIT0055","doi-asserted-by":"crossref","first-page":"643\u20134","DOI":"10.1016\/S2468-1253(20)30125-4","article-title":"Determining risk factors for mortality in liver transplant patients with COVID-19","volume":"5","author":"Webb","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2021012703151780200_CIT0056","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.kint.2020.04.002","article-title":"A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia","volume":"97","author":"Alberici","year":"2020","journal-title":"Kidney Int"},{"key":"2021012703151780200_CIT0057","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"2021012703151780200_CIT0058","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1111\/ajt.15928","article-title":"Clinical characteristics and immunosuppressants management of coronavirus disease 2019 in solid organ transplant recipients","volume":"20","author":"Zhong","year":"2020","journal-title":"Am J Transplant"},{"key":"2021012703151780200_CIT0059","first-page":"0","article-title":"Case report: a kidney transplant p","author":"Arpali","year":"2020","journal-title":"Transpl Infect Dis"},{"key":"2021012703151780200_CIT0060","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S2468-1253(20)30116-3","article-title":"COVID-19 in long-term liver transplant patients: preliminary experience from an Italian transplant centre in Lombardy","volume":"5","author":"Bhoori","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2021012703151780200_CIT0061","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.16120","article-title":"COVID-19 in recent kidney transplant recipients","author":"Shingare","year":"2020","journal-title":"Am J Transplant"},{"key":"2021012703151780200_CIT0062","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1111\/ajt.15897","article-title":"Novel coronavirus (SARS-CoV-2) infection in a renal transplant recipient: case report","volume":"20","author":"Ning","year":"2020","journal-title":"Am J Transplant"},{"key":"2021012703151780200_CIT0063","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1111\/ajt.15943","article-title":"Severe COVID-19 in a renal transplant recipient: a focus on pharmacokinetics","volume":"20","author":"Meziyerh","year":"2020","journal-title":"Am J Transplant"},{"key":"2021012703151780200_CIT0064","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13348","article-title":"Case series of six kidney transplanted patients with COVID-19 pneumonia treated with tocilizumab","author":"Mella","year":"2020","journal-title":"Transpl Infect Dis"},{"key":"2021012703151780200_CIT0065","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.eururo.2020.03.036","article-title":"COVID-19 in a kidney transplant patient","volume":"77","author":"Wang","year":"2020","journal-title":"Eur Urol"},{"key":"2021012703151780200_CIT0066","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1111\/ajt.15920","article-title":"Immunosuppressive therapy maintenance in a kidney transplant recipient SARS-CoV-2 pneumonia: a case report","volume":"20","author":"Bussalino","year":"2020","journal-title":"Am J Transplant"},{"key":"2021012703151780200_CIT0067","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/ajt.15902","article-title":"SARS Cov2 infection in a renal transplanted patient: a case report","volume":"20","author":"Seminari","year":"2020","journal-title":"Am J Transplant"},{"key":"2021012703151780200_CIT0068","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13338","article-title":"COVID-19 in an HIV-positive kidney transplant recipient","author":"Kumar","year":"2020","journal-title":"Transpl Infect Dis"},{"key":"2021012703151780200_CIT0069","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.16107","article-title":"Recovery from COVID-19 following hepatitis C, human immunodeficiency virus infection and liver transplantation","author":"M\u00fcller","year":"2020","journal-title":"Am J Transplant"},{"key":"2021012703151780200_CIT0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2020.04.071","article-title":"Incidence and patterns of COVID-19 among inflammatory bowel disease patients from the Nancy and Milan cohorts","author":"Allocca","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2021012703151780200_CIT0071","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/apt.15804","article-title":"2019 Novel coronavirus disease (COVID-19) in patients with inflammatory bowel diseases","volume":"52","author":"Taxonera","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"2021012703151780200_CIT0072","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1136\/gutjnl-2020-321411","article-title":"Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study","volume":"69","author":"Bezzio","year":"2020","journal-title":"Gut"},{"key":"2021012703151780200_CIT0073","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2020.05.032","article-title":"Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international registry","author":"Brenner","year":"2020","journal-title":"Gastroenterology"},{"key":"2021012703151780200_CIT0074","article-title":"Impact of anti-TNF and thiopurines medications on the development of COVID-19 in patients with inflammatory bowel disease: a nationwide VA cohort study","author":"Khan","year":"2020","journal-title":"Gastroenterology"},{"key":"2021012703151780200_CIT0075","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2020-217600","article-title":"Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: a monocentric survey","author":"Tomelleri","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2021012703151780200_CIT0076","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/annrheumdis-2020-217424","article-title":"Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies","volume":"79","author":"Monti","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2021012703151780200_CIT0077","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102575","article-title":"SARS-CoV-2 infection among patients with systemic autoimmune diseases","author":"Emmi","year":"2020","journal-title":"Autoimmun Rev"},{"key":"2021012703151780200_CIT0078","article-title":"What is the true incidence of COVID-19 in patients with rheumatic diseases?","author":"Favalli","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2021012703151780200_CIT0079","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.semarthrit.2020.05.001","article-title":"Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs","volume":"50","author":"Michelena","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"2021012703151780200_CIT0080","article-title":"COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs","author":"Conticini","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2021012703151780200_CIT0081","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2020-217888","article-title":"Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US \u201chot spot.\u201d","author":"D\u2019Silva","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2021012703151780200_CIT0082","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2020-217362","article-title":"Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept","author":"Duret","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2021012703151780200_CIT0083","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2020-217562","article-title":"Anti-inflammatory therapy may ameliorate the clinical picture of COVID-19","author":"Moutsopoulos","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2021012703151780200_CIT0084","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/annrheumdis-2020-217442","article-title":"COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD","volume":"79","author":"Mihai","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2021012703151780200_CIT0085","doi-asserted-by":"crossref","first-page":"e250","DOI":"10.1016\/S2665-9913(20)30095-3","article-title":"Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries","volume":"2","author":"Gianfrancesco","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"2021012703151780200_CIT0086","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.16527","article-title":"Safety of dupilumab in severe atopic dermatitis and infection of Covid-19: two case reports","author":"Ferrucci","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2021012703151780200_CIT0087","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.16619","article-title":"SARS-CoV-2 asymptomatic infection in a patient under treatment with dupilumab","author":"Caroppo","year":"2020","journal-title":"J Eur Acad Dermatology Venereol"},{"key":"2021012703151780200_CIT0088","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jaci.2020.05.005","article-title":"COVID-19 in a patient with severe chronic rhinosinusitis with nasal polyps during therapy with dupilumab","volume":"146","author":"F\u00f6rster-Ruhrmann","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"2021012703151780200_CIT0089","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1111\/jdv.16571","article-title":"SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor","volume":"34","author":"Balestri","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2021012703151780200_CIT0090","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1111\/jdv.16468","article-title":"SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor","volume":"34","author":"Messina","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2021012703151780200_CIT0091","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.16587","article-title":"Evolution of COVID-19 infection in 4 psoriatic patients treated with biological drugs","author":"Conti","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2021012703151780200_CIT0092","article-title":"Novel coronavirus disease (COVID-19) and biologic therapy for psoriasis: successful recovery in two patients after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","author":"Brownstone","year":"2020","journal-title":"Dermatol Ther (Heidelb)"},{"key":"2021012703151780200_CIT0093","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13706","article-title":"Psoriasis, COVID-19 and acute respiratory distress syndrome: focusing on the risk of concomitant biological treatment","author":"Magnano","year":"2020","journal-title":"Dermatol Ther"},{"key":"2021012703151780200_CIT0094","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJMc2009567","article-title":"Covid-19 in immune-mediated inflammatory diseases\u2014case series from New York","volume":"383","author":"Haberman","year":"2020","journal-title":"N Engl J Med"},{"key":"2021012703151780200_CIT0095","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/annrheumdis-2020-217903","article-title":"Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: a population-based study","volume":"79","author":"Salvarani","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2021012703151780200_CIT0096","doi-asserted-by":"crossref","first-page":"102120","DOI":"10.1016\/j.msard.2020.102120","article-title":"COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?","volume":"42","author":"Novi","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"2021012703151780200_CIT0097","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurol.2020.03.012","article-title":"Headache and multifocal white matter lesions: radiologically isolated syndrome or CADASIL?","author":"Mazoyer","year":"2020","journal-title":"Rev Neurol (Paris)"},{"key":"2021012703151780200_CIT0098","doi-asserted-by":"crossref","first-page":"102222","DOI":"10.1016\/j.msard.2020.102222","article-title":"Favorable outcome after COVID-19 infection in a multiple sclerosis patient initiated on ocrelizumab during the pandemic","volume":"43","author":"Ghajarzadeh","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"2021012703151780200_CIT0099","doi-asserted-by":"crossref","first-page":"102192","DOI":"10.1016\/j.msard.2020.102192","article-title":"COVID-19 in persons with multiple sclerosis treated with ocrelizumab\u2014a pharmacovigilance case series","volume":"42","author":"Hughes","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"2021012703151780200_CIT0100","article-title":"Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia","author":"Guilpain","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2021012703151780200_CIT0101","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.200507","article-title":"Incidence and clinical course of COVID-19 in patients with connective tissue diseases: a descriptive observational analysis","author":"Favalli","year":"2020","journal-title":"J Rheumatol"},{"key":"2021012703151780200_CIT0102","article-title":"Mild course of coronavirus disease 2019 and spontaneous severe acute respiratory syndrome coronavirus 2 clearance in a patient with depleted peripheral blood B-cells due to treatment with rituximab","author":"Fallet","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2021012703151780200_CIT0103","doi-asserted-by":"crossref","first-page":"102185","DOI":"10.1016\/j.msard.2020.102185","article-title":"Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: a case series of 60 patients from Madrid, Spain","volume":"42","author":"Montero-Escribano","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"2021012703151780200_CIT0104","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2020.04.013","article-title":"A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia","author":"Quinti","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"2021012703151780200_CIT0105","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.anai.2020.04.033","article-title":"The clinical observation of a patient with common variable immunodeficiency diagnosed as having coronavirus disease 2019","volume":"125","author":"Fill","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2021012703151780200_CIT0106","doi-asserted-by":"crossref","DOI":"10.1007\/s10461-020-02871-9","article-title":"The burden of COVID-19 in people living with HIV: a syndemic perspective","author":"Shiau","year":"2020","journal-title":"AIDS Behav"},{"key":"2021012703151780200_CIT0107","doi-asserted-by":"crossref","first-page":"117592","DOI":"10.1016\/j.lfs.2020.117592","article-title":"Ribavirin, remdesivir, sofosbuvir, galidesivir, and tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): a molecular docking study","volume":"253","author":"Elfiky","year":"2020","journal-title":"Life Sci"},{"key":"2021012703151780200_CIT0108","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N Engl J Med"},{"key":"2021012703151780200_CIT0109","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijid.2020.05.085","article-title":"Lack of antiviral activity of darunavir against SARS-CoV-2","volume":"97","author":"De Meyer","year":"2020","journal-title":"Int J Infect Dis"},{"key":"2021012703151780200_CIT0110","doi-asserted-by":"crossref","first-page":"104826","DOI":"10.1016\/j.phrs.2020.104826","article-title":"Darunavir does not prevent SARS-CoV-2 infection in HIV patients","volume":"157","author":"Riva","year":"2020","journal-title":"Pharmacol Res"},{"key":"2021012703151780200_CIT0111","doi-asserted-by":"crossref","first-page":"e314","DOI":"10.1016\/S2352-3018(20)30111-9","article-title":"COVID-19 in patients with HIV: clinical case series","volume":"7","author":"Blanco","year":"2020","journal-title":"Lancet HIV"},{"key":"2021012703151780200_CIT0112","doi-asserted-by":"crossref","DOI":"10.1097\/QAI.0000000000002411","article-title":"COVID-19 pneumonia in patients with HIV\u2014a case series","author":"Okoh","year":"2020","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2021012703151780200_CIT0113","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3018(20)30164-8","article-title":"Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort","author":"Vizcarra","year":"2020","journal-title":"Lancet HIV"},{"key":"2021012703151780200_CIT0114","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25955","article-title":"HIV\/SARS-CoV-2 co-infected patients in Istanbul, Turkey","author":"Altuntas Aydin","year":"2020","journal-title":"J Med Virol"},{"key":"2021012703151780200_CIT0115","article-title":"Clinical features and outcomes of HIV patients with coronavirus disease 2019","author":"Gervasoni","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021012703151780200_CIT0116","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa657","article-title":"Hospitalized patients with COVID-19 and HIV: a case series","author":"Childs","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021012703151780200_CIT0117","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.26077","article-title":"Clinical features and outcome of HIV\/SARS-CoV-2 coinfected patients in The Bronx, New York City","author":"Suwanwongse","year":"2020","journal-title":"J Med Virol"},{"key":"2021012703151780200_CIT0118","doi-asserted-by":"crossref","DOI":"10.1089\/apc.2020.0103","article-title":"A case series of five people living with HIV hospitalized with COVID-19 in Chicago, Illinois","author":"Ridgway","year":"2020","journal-title":"AIDS Patient Care STDS"},{"key":"2021012703151780200_CIT0119","doi-asserted-by":"crossref","DOI":"10.1007\/s15010-020-01438-z","article-title":"COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients","author":"H\u00e4rter","year":"2020","journal-title":"Infection"},{"key":"2021012703151780200_CIT0120","article-title":"Clinical characteristics and outcomes in people living with HIV hospitalized for COVID-19","author":"Shalev","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021012703151780200_CIT0121","article-title":"4 Cases: HIV and SARS-CoV-2 co-infection in patients from Long Island, New York","author":"Benkovic","year":"2020","journal-title":"J Med Virol"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaa863\/33555372\/ciaa863.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/72\/2\/340\/36115792\/ciaa863.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/72\/2\/340\/36115792\/ciaa863.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T04:42:34Z","timestamp":1667104954000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/72\/2\/340\/5864040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,27]]},"references-count":121,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,6,27]]},"published-print":{"date-parts":[[2021,1,27]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaa863","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,1,15]]},"published":{"date-parts":[[2020,6,27]]}}}